The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study - Marcus, Ronald N; McQuade, Robert D; Carson, William H; Hennicken, Delphine; Fava, Maurizio; Simon, Jeffrey S; Trivedi, Madhukar H; Thase, Michael E; Berman, Robert M (Journal of clinical psychopharmacology, 2008)
Keywords: Adult; Akathisia, Drug-Induced - etiology; Antidepressive Agents - adverse effects; Antidepressive Agents - therapeutic use; Aripiprazole; Citalopram - adverse effects; Citalopram - therapeutic use; Cyclohexanols - adverse effects; Cyclohexanols - therapeutic use; Depressive Disorder, Major - drug therapy; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Fatigue - chemically induced; Female; Fluoxetine - adverse effects; Fluoxetine - therapeutic use; Humans; Male; Middle Aged; Paroxetine - adverse effects; Paroxetine - therapeutic use; Piperazines - adverse effects; Piperazines - therapeutic use; Prospective Studies; Psychiatric Status Rating Scales - statistics & numerical data; Quinolones - adverse effects; Quinolones - therapeutic use; Sertraline - adverse effects; Sertraline - therapeutic use; Single-Blind Method; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride; Weight Gain - drug effects; Withholding Treatment - statistics & numerical data